Identifying Potential Effects of Liraglutide on Degenerative Changes
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Today Alzheimers disease can not be cured. Animal experiments have shown that the hormone
GLP-1 can improve memory in Alzheimer-prone mice.
The investigators hypothesis is that a 6-month treatment with the GLP-1 receptor stimulating
drug liraglutide will reduce the intracerebral amyloid deposition in the central nervous
system (CNS) in patients with Alzheimer's disease (AD) and thereby reduce the clinical
symptoms of the disease.